Pfizer’s COVID-19 vaccine was 73% effective in protecting children younger than 5 as Omicron spread in the spring
Vaccinations for babies, toddlers, and preschoolers opened in the U.S. in June after months of delay. Only about 6% of youngsters ages 6 months through 4 years had gotten at least one dose of a COVID-19 vaccine by mid-August, according to the American Academy of Pediatrics.
Health authorities authorized tot-sized vaccine doses made by Pfizer and its partner BioNTech based on a study showing they were safe and produced high levels of virus-fighting antibodies. But there was only preliminary data on how that translated into effectiveness againstThere were 21 COVID-19 cases among the 351 tots who got dummy shots—compared to just 13 among the 794 youngsters given three vaccine doses.The child cases primarily were caused by the BA.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The effect of COVID-19 on public confidence in the World Health Organization: a natural experiment among 40 countries - Globalization and HealthBackground At a time when a highly contagious pandemic and global political and economic turmoil are intertwined, worldwide cooperation under the leadership of an international organization has become increasingly important. This study aimed to estimate the effect of COVID-19 on public confidence in the World Health Organization (WHO), which will serve as a reference for other international organizations regarding the maintenance of their credibility in crisis management and ability to play a greater role in global health governance. Methods We obtained individual data from the World Values Survey (WVS). A total of 44,775 participants aged 16 and older from 40 countries in six WHO regions were included in this study. The COVID-19 pandemic was used as a natural experiment. We obtained difference-in-differences (DID) estimates of the pandemic’s effects by exploiting temporal variation in the timing of COVID-19 exposure across participants interviewed from 2017 to 2020 together with the geographical variation in COVID-19 severity at the country level. Public confidence in the WHO was self-reported by the respondents. Results Among the participants, 28,087 (62.73%) reported having confidence in the WHO. The DID estimates showed that the COVID-19 pandemic could significantly decrease the likelihood of people reporting confidence in the WHO after controlling for multiple covariates (adjusted OR 0.54, 95% CI: 0.49–0.61), especially during the global outbreak (0.35, 0.24–0.50). The effect was found in both younger individuals (0.58, 0.51–0.66) and older adults (0.49, 0.38–0.63) and in both males (0.47, 0.40–0.55) and females (0.62, 0.53–0.72), with a vulnerability in males (adjusted P for interaction = 0.008). Conclusion Our findings are relevant regarding the impact of COVID-19 on people’s beliefs about social institutions of global standing, highlighting the need for the WHO and other international organizations to shoulder the responsibility of global development for the
Read more »
'Wrong to scare people' with Covid messaging and 'empower' scientists, says Rishi SunakIt was 'wrong to scare people' with Covid messaging during the pandemic, Rishi Sunak has said
Read more »
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge | NEJMOriginal Article from The New England Journal of Medicine — Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge
Read more »
Severe COVID-19 increases risk of future cardiovascular eventsSevere COVID-19 increases risk of future cardiovascular events Coronavirus Disease COVID HeartDisease Cardiology CIDJournal Pfizer
Read more »
NHS and care staff will no longer be routinely tested for CovidDoctors, nurses, carers and other workers who do not have coronavirus symptoms will no longer be granted access to free testing.
Read more »